CME/CE

Menin Inhibitors in AML: Six Clinical Showdowns That Shape Real-World Practice

32:30

Faculty: Amer Zeidan, MBBS, MHS Faculty: Ghayas Issa, MD, MS

This chapterized expert interview examines six common clinical decision points encountered when incorporating menin inhibitors into the management of relapsed/refractory NPM1-mutated acute myeloid leukemia (AML). Faculty discuss evidence-informed approaches to treatment initiation, monitoring strategies, drug-drug interaction…